BlackRock
PHAR

BlackRock’s Pharming Group PHAR Stock Holding History

BlackRock’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-326
Closed -$2.69K – 5444
2024
Q3 		$2.69K Buy
+326
New +$2.58K ﹤0.01% 5093

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's PHAR Position: Q4 2024 in Review

BlackRock sold out of Pharming Group (PHAR) in Q4 2024, closing a stake of 326 shares — an estimated $2.69K sold.

BlackRock first reported a position in PHAR in Q3 2024 and held it in 1 quarter. The position peaked at $2.69K in Q3 2024. 5 funds tracked by Wall St. Rank hold PHAR as of Q4 2024.

  • BlackRock reported no remaining Pharming Group position as of Q4 2024 after selling out during the quarter.
  • BlackRock sold 326 Pharming Group shares in Q4 2024, an estimated $2.69K.
  • BlackRock first reported a position in Pharming Group in Q3 2024 and held it in 1 quarter.
  • BlackRock's Pharming Group position peaked at $2.69K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held Pharming Group as of Q4 2024.

Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.